Logos Global Management LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 4:27 pm Purchase | 2023-06-26 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Logos Global Management LP | 3,469,927 9.900% | 3,215,927 (+1266.11%) | Filing |
| 2023-07-18 4:01 pm Purchase | 2023-07-06 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Logos Global Management LP | 254,000 8.100% | 254,000 (New Position) | Filing |